Spectral AI Inc. (MDAI)
2.08
0.12 (6.12%)
At close: Jan 21, 2025, 3:59 PM
2.07
-0.24%
After-hours Jan 21, 2025, 07:45 PM EST
Company Description
Spectral AI, Inc. operates as an artificial intelligence (AI) company.
The company focuses on medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers.
Its products include DeepView, a predictive diagnostic device that offers clinicians an objective and immediate assessment of a wound's healing potential prior to treatment or other medical intervention.
The company is based in Dallas, Texas.
Spectral AI Inc.
| Country | United States |
| IPO Date | Apr 6, 2021 |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 78 |
| CEO | Wensheng Fan |
Contact Details
Address: 2515 McKinney Avenue Dallas, Texas United States | |
| Website | https://www.spectral-ai.com |
Stock Details
| Ticker Symbol | MDAI |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001833498 |
| CUSIP Number | 84757T105 |
| ISIN Number | US84757T1051 |
| Employer ID | 00-0000000 |
| SIC Code | 6770 |
Key Executives
| Name | Position |
|---|---|
| Erich L. Spangenberg | Chief Executive Officer of Health care & Director |
| Wensheng Fan | Co-Founder, Chief Innovation Strategist & Senior Advisor to the Chief Executive Officer |
| Stan Micek | Interim Chief Operating Officer |
| Vincent Stanley Capone | Chief Financial Officer, General Counsel & Corporate Secretary |
| Christine Marks | Vice President of Marketing & Commercialization |
| David Bronson | Financial Controller |
| Dr. John Michael DiMaio M.D. | Founder & Chairman |
| Jeremiah A. Sparks MBA | Chief Commercialization Officer |
| Prof. Paul Chadwick | Executive Vice President of UK & EMEA |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Dec 23, 2024 | 8-K | Current Report |
| Dec 12, 2024 | 424B5 | Filing |
| Dec 11, 2024 | 8-K | Current Report |
| Dec 09, 2024 | 424B5 | Filing |
| Dec 04, 2024 | 424B3 | Filing |
| Nov 21, 2024 | S-3 | Filing |
| Nov 18, 2024 | 424B5 | Filing |
| Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Nov 06, 2024 | 10-Q | Quarterly Report |
| Oct 16, 2024 | S-3 | Filing |